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Abstract
Background: The silver homologue(SILV) gene plays a major role in melanosome development.
SILV is a target for studies concerning melanoma diagnostics and therapy in humans as well as on
skin and coat color pigmentation in many species ranging from zebra fish to mammals. However,
the precise functional cellular mechanisms, in which SILV is involved, are still not completely
understood. While there are many studies addressing SILV function upon a eumelaneic pigment
background, there is a substantial lack of information regarding the further relevance of SILV, e.g.
for phaeomelanosome development.
Results: In contrast to previous results in other species reporting SILV expression exclusively in
pigmented tissues, our experiments provide evidence that the bovine SILV gene is expressed in a
variety of tissues independent of pigmentation. Our data show that the bovine SILV gene generates
an unexpectedly large number of different transcripts occurring in skin as well as in non-pigmented
tissues, e.g. liver or mammary gland. The alternative splice sites are generated by internal splicing
and primarily remove complete exons. Alternative splicing predominantly affects the repeat domain
of the protein, which has a functional key role in fibril formation during eumelanosome
development.
Conclusion: The expression of the bovine SILV gene independent of pigmentation suggests SILV
functions exceeding melanosome development in cattle. This hypothesis is further supported by
transcript variants lacking functional key elements of the SILV protein relevant for eumelanosome
development. Thus, the bovine SILV gene can serve as a model for the investigation of the putative
additional functions of SILV. Furthermore, the splice variants of the bovine SILV gene represent a
comprehensive natural model to refine the knowledge about functional domains in the SILV
protein. Our study exemplifies that the extent of alternative splicing is presumably much higher
than previously estimated and that alternatively spliced transcripts presumably can generate
molecules of deviating function compared to their constitutive counterpart.
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Background
The silver homologue(SILV) gene has been a target for
many investigations concerning development of melano-
somes, which are the specific pigment carrying compart-
ments within melanophores, e.g. in melanocytes. In
humans,  SILV  plays a major role in studies regarding
melanoma diagnosis and therapy, because SILV is a sensi-
tive melanoma marker on transcript and protein level
[1,2] and represents a melanoma specific antigen recog-
nized by tumor infiltrating cytotoxic T lymphocytes [3].
The SILV protein also known as PMEL17, GP100 or ME20
[4] is crucial for proper formation and maturation of
melanosomes. In stage II melanosomes, processed SILV
protein aggregates to form fibrils, to which presumably
the eumelanin pigment is attached [5]. Due to its role in
melanosome development, SILV has also been subject to
several studies investigating the genetic background of
coat color.
Coat color phenotype in mammals is dependent on a
series of genes determining distribution of melanocytes
(e.g. KIT, [6]), synthesis of the two essential pigments,
eumelanin (black) and phaeomelanin (red) (e.g. MC1R,
[7]), and intra- and intercellular transport mechanisms of
proteins relevant for coat color expression (e.g. MATP,
[8]). In cattle, variants in the MC1R gene result in exclu-
sively eumelaneic (black) or phaeomelaneic (red) skin
[9]. Spotted individuals exhibit delimited, white skin
areas lacking melanocytes similar to piebald mice [10].
Similar to other species, dilution loci resulting in a diluted
type of the original coat color are known in cattle, e.g. the
Dilution locus in the Charolais breed (Dc). The putative
role of SILV  for various coat color dilution loci was
described in a number of species, including mouse, dog,
chicken, horse, and cattle [11-16]. There is concurring
indication that concerning coat color the effect of a muta-
tion in the SILV gene in mouse, horses and dogs seems to
be restricted to the dilution of eumelaneic pigment. This
is underlined by experiments in mice indicating that SILV
expression seems to be restricted to melanocytes express-
ing eumelanin [17]. In cattle, however, there is still some
controversy regarding the potential role of SILV in phae-
omelanosome development, because up to now there is
no unequivocal experimental evidence rejecting or propa-
gating SILV mutations as causal background for phae-
omelanin dilution [14,18]. First reports on splice variants
for the human SILV gene [19] and a retroposon insertion
in intron 10 of the canine SILV gene that seems to affect
the correct splicing of the gene in merle dogs [12] raise the
question whether putative splice variants of the SILV gene
may be specifically involved in melanosome develop-
ment. Comprehensive studies in humans revealed that
alternative splicing is a frequent mechanism altering spa-
tial expression pattern and function of proteins [20,21].
In the present study, we present a comprehensive descrip-
tion of the complex expression pattern of the bovine SILV
gene in pigmented and non-pigmented tissues. Multiple
transcript variants affecting functional key domains of the
SILV protein indicate that the bovine SILV gene may serve
as a model for investigations about alternative splicing to
generate molecules of obviously deviating function com-
pared to constitutive transcripts.
Results
Identification of the SILV transcription start site
Analysis of several 5'RACE clones from total RNA of
eumelaneic, non-dilute (black) skin indicated a sharp
peak of transcription start sites (TSS) at position -28 bp to
the A of the translation start ATG of the SILV gene (Gen-
Bank: EF065525). No further promoters were detected.
The SILV transcription start obtained in this study adds an
additional 7 bp to the previously deposited bovine SILV
cDNA sequence [14]. The cDNA sequence generated by
this experiment based on CAP carrying full length mRNA
confirmed previous findings about the structure of the
bovine SILV gene comprising 2046 bp organized in 11
exons (Figure 1) and encoding 649 amino acids. Aligning
the obtained SILV  cDNA sequence with the bovine
genomic contig NCBI: NW_001495046 [22]) indicated
that the bovine SILV gene spans a total of 8107 bp with
introns sizes ranging from 108 to 2220 bp. A TTATA motif
representing the putative TATA box of the SILV promoter
is located 30 bp upstream of the transcription initiation
site.
Detection of splice variants
Multiple RT-PCR fragments were detected when amplify-
ing SILV cDNA from RNA of eumelaneic (black), non-
diluted skin with primers in the 5' and 3' UTR of the SILV
gene (5UTRF1 – E11R2; Table 1, 2). This diversity of tran-
scripts was also obtained with a primer combination
spanning exon 1 to exon 7 (E1F3 – E7R1) of the bovine
SILV gene (Figure 2). While the constitutive transcripts
(2039 bp or 1430 bp, respectively, confirmed by sequenc-
ing) were dominating, further fragments up to 900 bp
smaller than the constitutive transcript were identified
with both primer pairs. In contrast, cloned SILV constitu-
tive cDNA yielded only the expected 2039 or 1430 bp PCR
fragment, respectively.
A series of PCR amplifications in SILV cDNA samples with
primers dissecting the transcribed SILV sequence into
smaller segments enabled a better discrimination of the
generated fragments. Exons 6, 8 and 9 were identified as
putative regions for alternative splicing events, because at
least two RT-PCR fragments could be unambiguously dis-
criminated with primer combinations spanning exon 5 –
7 (E5F1 – E7R1) and exon 7 – 11 (E7F1 – E11R2). In con-
trast, only single RT-PCR fragments were observed for theBMC Genomics 2007, 8:335 http://www.biomedcentral.com/1471-2164/8/335
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primer combinations covering exon 1 – 3, exon 3 – 5,
exon 5 – 6, exon 9 – 11 and exon 10 – 11. Notably, all
identified fragments were present in all differentially pig-
mented skin samples investigated (Table 2, Figure 3). Our
data show that the expression of the bovine SILV gene is
not restricted to eumelaneic (black), non-dilute (Dcd/
Dcd) skin, but also occurs in skin expressing exclusively
phaeomelanin. Furthermore, also white skin sections of
spotted individuals with eumelaneic or phaeomelaneic
background showed SILV gene expression as well as the
crème white skin of a eumelaneic homozygous dilute
DcD/DcD individual.
The SILV transcripts additional to the constitutive frag-
ment that had been identified by RT-PCR were isolated
from the agarose gel and sequenced to reveal the specific
DNA sequence of the different fragments. Alignment of
the obtained sequences to the reference constitutive cDNA
(GenBank: EF065525) showed that the additional SILV
transcripts lacked different parts of the SILV mRNA (Fig-
ure 1). With primers spanning exon 5 to exon 7 (E5F1 –
E7R1), three alternative transcripts (according to GenBank:
EF065525) were characterized: ∆660–1340 lacking 681
bp corresponding to the entire exon 6, ∆816–1340 lacking
525 bp from the 3' end of exon 6 and ∆1185–1340 lack-
ing 156 bp from the 3' end of exon 6. With primers span-
Structure of the bovine SILV mRNA including alternative transcripts Figure 1
Structure of the bovine SILV mRNA including alternative transcripts. Position of exons (open boxes) and introns 
(solid line) in the SILV genomic sequence are indicated. Protein domains according to [4,31] are shown: SIG: signal peptide, 
NTD: N-terminal domain, PKD: polycystic kidney domain, RPT: repeat domain, KRG: Kringle-like domain, TM: transmembrane 
domain, CTD: C-terminal domain, G1, G2, G3: undefined domains. E: SILV exon.* Numbers in the SILV protein diagram repre-
sent the first amino acid of the respective domain. ** Numbers for the SILV transcripts represent the first nucleotide for the 
respective exon or the last constitutive nucleotide of an alternative transcript. fm: frame shift mutation. Length [in bp] of the 
alternative c SILV transcripts is indicated in red (left), the missing part relative to the constitutive SILV transcript (nucleotides 
and amino acids) is indicated in green (right).
Cleavage site
Human insertion splice variant (7aa)
1788
1365
1203
1890
1521
2037
1109
810
921
1068
16 5 9 2046 1341
681 bp
227 aa
1 497 1341 2046
843 bp
281 aa
1 1184 1341 2046
156 bp
52 aa
1 815 1341 2046
525 bp
175 aa
1 1331 1341 2046
9 bp
3 aa
2046 104
1236 bp
412 aa
1 1341
1 1654 1749 2046
843 / 94 bp
281aa /fm.
497 1341
2046
978 bp
326 aa
362 1 1341
2046 215
1125 bp
375 aa
1 1341
1 104 363 2046
258 / 9 bp
86 / 3 aa
1331 1341
2220 bp 145 bp 376 bp 256 bp 905 bp 243 bp
109 bp
625 bp 1075 bp 108 bp
genomic
**
SIG NTD PKD G1 G2 KRG TM CTD RPT
1 29 256 293 315 431 502 554 576 613 649
G3 protein
*
E5 E6 E7 E8 E9 E10 E11
1 105 216 363
E1 E2 E3 E4
498 660 1341 1458 1543 1749 1837 2046
[bp]
Human deletion splice variant (    42 aa)
5´ and 3´ UTR
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ning exon 7 to exon 11 (E7R1 – E11R2), we obtained an
alternative transcript ∆1655–1748 lacking 94 bp from the
3' end of exon 9. Furthermore, sequencing of an addi-
tional RT-PCR transcript amplified with primers from
exon 1 and exon 11 (5UTRF1 – E11R2) detected a SILV
cDNA ∆498–1340/∆1655–1748 lacking exon 5, exon 6
and 94 bp from the 3' end of exon 9 (Figure 1).
Diversity in SILV transcripts was also confirmed in the
course of our 5'RACE experiments. Several clones contain-
ing inserts smaller than the expected size (1441 bp) were
detected. Sequencing of the respective clones revealed
SILV  cDNAs starting from the identified transcription
start, but devoid of distinct other regions in the remaining
SILV mRNA. On the one hand, we received transcripts
confirming already detected alternative splice variants
e.g., ∆498–1340, ∆660–1340, ∆816–1340, and ∆1185–
1340. Additionally, we identified two further internal
splice sites generating a transcript ∆105–362 (skipping
exons 2 and 3)/∆1332–1340 (lacking 9 bp at the 3' end of
exon 6 (Figure 1).
In order to obtain indication whether combinations of
alternative splicing events occurred, we sequenced a col-
lection of clones from a plasmid library containing SILV
RT-PCR products of variable size generated by cDNA
amplification of eumelaneic (black), non-dilute (Dcd/Dcd)
skin with primers spanning exon 1 to exon 7 (E1F3 – E7R1).
Alignment of the generated sequences to the SILV consti-
tutive transcript confirmed previously detected transcripts
and yielded an additional new series of transcripts (Figure
1) with deleted exons: ∆363 – 1340 (lacking exon 4 – 6),
∆216 – 1340 (lacking exon 3 – 6) and ∆105 – 1340 (lack-
ing exon 2 – 6).
Only some alternative internal splice sites completely
conformed to the GT-AG rule for splice donor and splice
acceptor sites. Notably, the alternative splice sites did not
affect the reading frame of the transcript except for ∆498–
1340/∆1655–1748. In the transcript ∆498–1340/∆1655–
1748, a premature stop codon is generated at position
c.1805.
Confirmation of SILV splice variants in differentially 
pigmented skin
In order to confirm alternative splice sites in the bovine
SILV gene, we developed splice variant specific RT-PCR
tests for an exemplary subset of the detected splice vari-
ants (Table 3, Figure 4). Splice variant profiling revealed
the alternative splice variants ∆498–1340,  ∆816–1340
and  ∆1185–1340 in all differentially pigmented skins
(Table 4). In contrast, we obtained a specific pattern for
∆105–362, which was not detected in non-pigmented,
white skin of spotted individuals heterozygous for the
Table 1: Primers for reverse transcription and amplification in the bovine SILV gene
Name Positiona Exon Sequence (5' – 3')
E1F3 69 1 TGATGGGTGTTCTTCTGGCTG
E3F1 280 3 CTCTATTGCCTTGCACTTTCC
E3R1 362 3 CATTGATGATGGTGTTGTTGG
E5R1 656 5 TAATGGTGAAGGCTGAACTGG
E5F1 575 5 AACATGGAAGTGACTGTCTACC
E7R1 1430 7 AGCCATAGCGATACAGAACAC
E7F1 1360 7 GGATGACACTGCCACCTTAG
E11R2 2046 11 AGGGAAGACCAGAGAAAAGAC
E6F2 952 6 CACTACAGATAGGCATGTGAC
E6R2 1030 6 GCCCATGACTTCTGTAGTAGG
E10F1 1773 10 CTCCTCTGTTCGTGGGCATC
E9F1 1643 9 GTTTTGCACCAGGTACTGAAG
RACE_E7N 1441 7 CAGGGTGAGGGAAAAGGAGCCATAG
5UTRF1 8 1 GTTGCTGGAAGGAAGAACAGG
SPex23F1 88 1/4 TGTAGGGACCACAGAAGGGAG
E5R1 656 5 TAATGGTGAAGGCTGAACTGG
SPex56F1 481 4/7 TGTCTGGAAGACCTGGGGCT
E9R2 1587 9 TGACACCCTGGCGATGAGATG
E5F2 565 5 GGGCACATATAACATGGAAGTG
SPex6R1 1358 7/5 GCAGGGGACTCAGGGAGCCAG
SPex6AF1 798 6/7 CCTACACCTGGGACTTTGGCT
SPex6BF1 1167 6/7 CAACTGCAAAAGCTACAGGCT
E7F2 1409 7 TGTGTTCTGTATCGCTATGGCTC
SPex9R1 1767 9/10 CTGAGGCCTGCTTCTTGCCCTG
a Position within the bovine SILV mRNA (according to GenBank: EF065525). Underlined, bold sequence: nucleotides specific for alternative splice 
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Table 2: Regions of the bovine SILV mRNA tested for expression by RT-PCR in skin and non-pigmented body tissues
Primer combination Region Expected 
fragment [bp]
Observed fragment [bp]
Eumelaneic skin Phaeomelaneic skin Non-pigmented tissues
5UTRF1 – E11R2 exon 1 – exon 11 2039 2039, 1102 and multiple further fragments n.a. n.a.
E1F3 – E7R1 exon 1 – exon 7 1430 1430 and further multiple bands n.a. n.a.
E1F3 – E3R1 exon 1 – exon 3 294 294 294 n.a.
E3F1 – E5R1 exon 3 – exon 5 377 377 377 n.a.
E5F1 – E7R1 exon 5 – exon 7 856 856, 700, 331, 175 856, 700, 331, 175 856, 700, 331, 175 
(pg, tg, ki, ag, li, lu, he, br, ru, if, sf, sf, mg, fu, co, je, mu)
E7F1 – E11R2 exon 7 – exon 11 687 687; 593 687; 593 n.a.
E6F2 – E7R1 exon 6 – exon 7 479 479, 324 479, 324 n.a.
E5F1 – E6R2 exon 5 – exon 6 456 456 456 n.a.
E9F1 – E11R2 exon 9 – exon 11 404 404 404 404 (pg, tg, ki, ag, li, lu, he, br, ru, if, sf, sf, mg, fu, co, je, mu)
E10F1 – E11R2 exon 10 – exon 11 274 274 274 n.a.          
E1F3 – E5R1 exon 1 – exon 5 588 n.a. n.a. 588 (pg, tg, ki, ag, li, lu, he, br, ru, if, sf, sf, mg, fu, co, je, mu)
pg: pituitary gland, tg: thyroid gland, ki: kidney, ag: adrenal gland, li: liver, lu: lung, he: heart, br: brain, ru: rumen, if: intestinal fat, sf: subcutaneous fat, pf: perirenal fat, mg: mammary gland, du: duodenum, 
co: colon, je: jejunum, mu: skeletal muscle. n.a.: not analyzedBMC Genomics 2007, 8:335 http://www.biomedcentral.com/1471-2164/8/335
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dilute locus (DcD/Dcd) regardless whether on a eumela-
neic or a phaeomelaneic background. Notably, non-pig-
mented white skin of a spotted, homozygous non-dilute
(Dcd/Dcd) individual exhibited this splice site albeit at a
lower level than the pigmented counterpart. Skin with a
crème white coat color characteristic for individuals
homozygous at the dilution locus DcD/DcD also displayed
the alternative splicing ∆105-362. It has to be noted that
crème white skin has an essentially pigmented back-
ground with melanocytes [23], however, pigmentation is
diluted to almost invisibility. In contrast, non-pigmented
skin of spotted or piebald individuals is devoid of
melanocytes resulting in a white coat color [10].
Analysis of tissue specific SILV gene expression
RT-PCR revealed a specific expression of the bovine SILV
gene in all 17 investigated tissues from an adult individ-
ual: pituitary gland, thyroid gland, kidney, adrenal gland,
liver, lung, heart, brain, rumen, intestinal fat, subcutane-
ous fat, perirenal fat, mammary gland, duodenum, colon,
jejunum, skeletal muscle. All three SILV primer combina-
tions tested spanning exon 1 to exon 5 (E1F3 – E5R1), exon
5 to exon 7 (E5F1 – E7R1) and exon 9 to exon 11 (E9F1 –
E11R2) confirmed this observation (Table 2). The relative
amount as indicated by semi-quantitative RT-PCR dif-
fered between tissues: a strong SILV expression equivalent
to skin was seen in a number of tissues with very divergent
functions, e.g. thyroid gland and colon, whereas SILV was
only weakly expressed in brain, muscle and fat tissues
(Figure 5). Analysis with primers spanning exon 5 to exon
7 (E5F1 – E7R1) revealed at least two PCR fragments for all
tissues with a pattern similar to that obtained for differen-
tially pigmented skin tissues.
While alternative splice variants were rather uniformly
distributed across the differentially pigmented skins, sub-
stantial variation was seen for the other tissues (Table 4).
Only transcript variant ∆105–362 was tissue-specific for
skin. Whereas splice variant ∆816–1340 could be detected
in all seven tissues tested (Figure 6), ∆1185–1340 was
only found in mammary gland at a low level.
Discussion
Structure of the bovine SILV gene
The bovine SILV gene shows a strong structural homology
with the respective gene in human and mouse. The bovine
mRNA (GenBank: EF065525) is separated into 11 exons
and revealed a homology of 87% to the human
(NM_006928.3) and 83% to mouse mRNA
(NM_021882.4). At protein level, the similarities were 78
or 73%, respectively. The sharp peak of transcription start
sites detected in CAP finding RACE experiments and the
putative TATA box of the SILV promoter located 30 bp
upstream correspond to the classical pattern of TATA box
promoter architecture characteristic for genes highly con-
RT-PCR products in the SILV gene in eumelaneic black bovine  skin Figure 2
RT-PCR products in the SILV gene in eumelaneic 
black bovine skin. RT-PCR products were generated from 
pigmented, eumelaneic (black) bovine skin with primers span-
ning SILV exon 1 to exon 7 (E1F3/E7R1). M: DNA marker, 1: 
cloned constitutive SILV cDNA, 2: cDNA from eumelaneic 
(black), non-dilute (Dcd/Dcd) skin
Expression of SILV in eumelaneic and phaeomelaneic bovine  skin Figure 3
Expression of SILV in eumelaneic and phaeomelaneic 
bovine skin. RT-PCR products for the bovine SILV region 
spanning exon 5 to exon 7 were generated with primer E5F1 
– E7R1 in differentially pigmented bovine skin. 1: non-pig-
mented skin from a heterozygous dilute (DcD/Dcd), eumela-
neic (ED/ED) spotted individual; 2: pigmented skin from a 
heterozygous dilute (DcD/Dcd), eumelaneic (ED/ED) spotted 
individual; 3: crème white skin from a homozygous dilute 
(DcD/DcD), eumelaneic (ED/ED) non-spotted individual; 4: non-
pigmented skin from a heterozygous dilute (DcD/Dcd), phae-
omelaneic (Ee/Ee) spotted individual; 5: pigmented skin from a 
homozygous non-dilute (Dcd/Dcd), eumelaneic (ED/Ee) spotted 
individual; M: markerBMC Genomics 2007, 8:335 http://www.biomedcentral.com/1471-2164/8/335
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served in evolution [24]. Our RACE experiments in the
eumelaneic (black) non-dilute (Dcd/Dcd) skin yielded
essentially an identical transcription start compared to a
SILV  mRNA obtained by 5'RACE from a homozygous
dilute (DcD/DcD), crème-white skin [18]. Thus, the use of
alternative transcription starts can be formally excluded as
the background for differences in coat color between
dilute and non-dilute individuals.
SILV transcription in phaeomelaneic and non-pigmented 
tissues
Taking advantage of our animal model with individuals
expressing exclusively eumelanin or phaeomelanin, our
RT-PCR results prove that in cattle SILV expression in skin
is not restricted to areas with eumelanocytes, because we
also found SILV transcripts in phaeomelaneic and non-
melaneic skin. This result is in contrast to previous reports
in mice [17] indicating that SILV expression could only be
detected in cells synthesizing eumelanin. Whereas there
are many studies about the melanophore-specific expres-
sion of SILV in the literature (reviewed by [4]), only one
report in humans also describes SILV to be ubiquitously
expressed [25]. This result is supported by 112 ESTs iso-
lated from non-pigmented tissues in a total of 785 human
SILV  ESTs listed in the NCBI Unigene database [26]).
Although no conclusion regarding SILV transcription can
be drawn from bovine Unigene data base entries, our own
experiments clearly reject the hypothesis that SILV expres-
sion is specific to eumelanocytes in cattle. Expression out-
side of pigmented tissues indicates that products of the
bovine  SILV  gene seem to have a new, up to now
unknown function additional to fibril formation in the
course of melanosome development. Chakraborty et al.
postulate a catalytic role of SILV in melanin synthesis [27].
But as melanin synthesis is restricted to melanophores in
skin, uvea and other pigmented tissues [28], involvement
of SILV in melanin synthesis would not explain SILV
expression in tissues without melanophores. Conse-
quently, the additional role of SILV expression postulated
from our study has to exceed melanophore specific func-
tions. Up to now, it is completely unclear, which role SILV
transcription may play in e.g. thyroid gland or colon, two
tissues with extremely different cell type composition, for
which a high SILV expression was detected in our experi-
ments. If indeed human SILV  expression is also not
restricted to melanophores as indicated by [25], cattle
Table 4: Expression of bovine SILV splice variants by splice site specific RT-PCR in differentially pigmented skin and non-pigmented 
tissues
Tissues ∆105–362 ∆498–1340 ∆660–1340 ∆816–1340 ∆1185–1340 ∆1655–1748
Non-pigmented, heterozygous dilute, eumelaneic - + + + ++ +
pigmented, heterozygous dilute, eumelaneic ++ ++ + ++ ++ ++
pigmented, homozygous dilute, eumelaneic + ++ + ++ ++ ++
Non-pigmented, heterozygous dilute, phaeomelaneic - + + + ++ +
Pigmented, heterozygous dilute, phaeomelaneic + ++ + ++ ++ ++
Non-pigmented, homozygous non-dilute, eumelaneic + ++ + ++ ++ ++
Pigmented, homozygous non-dilute, eumelaneic ++ ++ + ++ ++ ++
liver - - - + - -
duodenum - - - + - -
pituitary gland - - - + - -
lung - + + + - -
heart - - - + - -
kidney - + - + - +
mammary gland - + - + + +
-: no expression detected, + expression detected, ++ enhanced expression detected
Table 3: Splice site specific RT-PCR primer combinations applied for the detection of alternative bovine SILV transcripts
Alternative splice site Upstream primer Downstream primer Expected alternative 
transcript [bp]
∆105–362 SPex23F1 TGTAGGGACCACAGAAGGGAG E5R1 TAATGGTGAAGGCTGAACTGG 311
∆498–1340 SPex56F1 TGTCTGGAAGACCTGGGGCT E9R2 TGACACCCTGGCGATGAGATG 264
∆660–1340 E5F2 GGGCACATATAACATGGAAGTG SPex6R1 GCAGGGGACTCAGGGAGCCAG 113
∆816–1340 SPex6AF1 CCTACACCTGGGACTTTGGCT E9R2 TGACACCCTGGCGATGAGATG 265
∆1185–1340 SPex6BF1 CAACTGCAAAAGCTACAGGCT E9R2 TGACACCCTGGCGATGAGATG 265
∆1655–1748 E7F2 TGTGTTCTGTATCGCTATGGCTC SPex9R1 CTGAGGCCTGCTTCTTGCCCTG 265
Underlined, bold sequence: nucleotides specific for alternative splice site.BMC Genomics 2007, 8:335 http://www.biomedcentral.com/1471-2164/8/335
Page 8 of 13
(page number not for citation purposes)
may serve as an appropriate model to investigate its
potential function in non-melanophores.
Alternative splicing in SILV affecting functionally relevant 
domains
RT-PCR with an overlapping panel of primer pairs indi-
cated nine alterative splice sites in the bovine SILV gene
resulting in splicing of cryptic introns predominantly
affecting exon 6, but also exons 2, 3, 4, 5 and exon 9. Thus,
the splicing pattern comprises the use of single or com-
bined cassette exons and alternative 5' splice sites result-
ing predominantly in deletions of single or multiple
exons, which is in line with other comprehensive studies
investigating alternative splicing [21]. Sequence align-
ment of the bovine SILV cDNA with the nine cattle ESTs
homologous to SILV, which are deposited in the Unigene
database [26], did not indicate alternative splicing. How-
ever, the confirmed alternative SILV transcripts in cattle
from our study are in line with previous experiments in
humans describing two alternative splice sites in exon 6
and exon 9 of the SILV gene [19]. The extent of alternative
splicing seen in cattle exceeds the number of published
alternative transcripts in humans substantially, and we
even cannot exclude that further splice variation is present
in cattle. The Alternative Splicing Database [29,30] col-
lecting electronic data on constitutive and alternative tran-
scripts lists entries exclusively for human SILV  and
indicates that the number of alternative transcripts in
humans is also presumably higher than presently consid-
ered. Interestingly, humans and cattle are the only species
for which alternative transcripts have been experimentally
established [19,29]. No additional transcripts are pub-
lished e.g. in mice.
Comparative analysis of the bovine SILV protein with the
respective counterpart in human according [4] suggested
that several functional domains of the SILV protein as
defined by [31] should be affected by alternative splicing
Splice site specific SILV RT-PCR in differentially pigmented bovine skin Figure 4
Splice site specific SILV RT-PCR in differentially pigmented bovine skin. A. Detection of bovine SILV splice variant 
∆105–362 in differentially pigmented skin. RT-PCR products generated by splice site specific RT-PCR with primers SPex23F1 – 
E5R1. M: marker; C: negative control, 1: non-pigmented skin from a heterozygous dilute (DcD/Dcd), eumelaneic (ED/ED) spotted 
individual; 2: pigmented skin from a heterozygous dilute (DcD/Dcd), eumelaneic (ED/ED) spotted individual; 3: crème white skin 
from a homozygous dilute (DcD/DcD), eumelaneic (ED/ED) non-spotted individual ; 4: non-pigmented skin from a heterozygous 
dilute (DcD/Dcd), phaeomelaneic (Ee/Ee) spotted individual; 5: pigmented skin from a heterozygous dilute (DcD/Dcd), phaeomela-
neic (Ee/Ee) spotted individual; 6: non-pigmented skin from a homozygous non-dilute (Dcd/Dcd), eumelaneic (ED/Ee) spotted indi-
vidual; 7: pigmented skin from a homozygous non-dilute (Dcd/Dcd), eumelaneic (ED/Ee) spotted individual. B. RT-PCR products 
generated with GAPDH primers.BMC Genomics 2007, 8:335 http://www.biomedcentral.com/1471-2164/8/335
Page 9 of 13
(page number not for citation purposes)
in cattle. Splice variant ∆105–362 characterized by the
complete skipping of exons 2 and 3 results in loss of the
proximal part of the N terminal domain (NTD) of the
bovine SILV protein. Thus, skipping of exons 2 and 3
would affect the posttranslational modification of the
protein substantially, because the NTD carries the major-
ity of SILVs' glycosylation sites as reviewed by [4]. The
alternative transcripts ∆363–1340,  ∆498–1340 and
∆660–1340 lack 326, 281 or 227 amino acids of the con-
stitutive transcript, respectively, representing the C termi-
nal part of the N terminal domain and the entire
Polycystic kidney disease (PKD) and Repeat (RPT)
domains. While the PKD has an immunoglobulin folding
structure and is thought to mediate protein-protein inter-
actions, the RPT domains seems to be necessary for fibril
formation in melanosomes [31]. The entire RPT domain
Expression of SILV in a collection of non-pigmented bovine tissues Figure 5
Expression of SILV in a collection of non-pigmented bovine tissues. A: SILV RT-PCR products generated with primers 
spanning exon 5 to exon 7 (E5F1 – E7R1) in RNA from non-pigmented tissues; sk: skin, pg: pituitary gland, tg: thyroid gland, ki: 
kidney, ag: adrenal gland, li: liver, lu: lung, he: heart, br: brain, ru: rumen, if: intestinal fat, pf: perirenal fat, sf: subcutaneous fat, 
mg: mammary gland, du: duodenum, co: colon, je: jejunum, mu: skeletal muscle. B. RT-PCR products generated with GAPDH 
primers in different non-pigmented tissues.
Splice site specific SILV RT-PCR in non-pigmented bovine tissues Figure 6
Splice site specific SILV RT-PCR in non-pigmented bovine tissues. Detection of SILV splice variant ∆816–1340 by splice 
site specific RT-PCR with primers SPex6AF1 – E9R2 in RNA from non-pigmented tissues. mg: mammary gland, ki: kidney, he: 
heart, lu: lung, pg: pituitary gland, du: duodenum, li: liver, sk: skin. M: marker; C: negative controlBMC Genomics 2007, 8:335 http://www.biomedcentral.com/1471-2164/8/335
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is also missing in the ∆816–1340 transcript in addition to
the distal PKD domain. Transcript ∆1185–1340 lacks the
distal part of the RPT domain, whereas ∆1332–1340 is
devoid of 3 amino acids of the Gap2 domain. Splice vari-
ant ∆1655–1748 is the only transcript with a disrupted
reading frame and a premature stop codon generating a
truncated protein without transmembrane and C terminal
domain or possibly inducing a nonsense-mediated mRNA
decay [32]. While the Kringle-like domain and the trans-
membrane domain seem to be rather invariable, the RPT
domain is most frequently affected by the different splice
variants in our data set. Experiments with human SILV
deletion constructs showed that a protein lacking the
Repeat domain (∆RPT SILV) showed an appropriate intra-
cellular trafficking [31]. However, HELA cells overexpress-
ing ∆RPT SILV formed only abnormal fibrils, indicating
that the RPT domain plays a crucial role in the develop-
ment of the striated fibrillar structure in melanosomes.
Hoashi et al. [31] used HMB45, an antibody frequently
employed for melanoma diagnostic as a probe specific for
melanosomal fibrils and showed that its epitope is
located in the second and third amino acid repeat of the
RPT domain. Thus, bovine transcripts lacking the respec-
tive part of the RPT domain (like 498–1340, ∆660–1340
and ∆816–1340 in our study) should not be able to form
intact fibrils, a process central to appropriate melanosome
development as determined for human SILV. Interest-
ingly, the two of the four isoforms of SILV in humans due
to alternative splicing also affect the RPT domain albeit
not the epitope for HMB45 [31]. The alternative splice
variants lacking entire functional domains as confirmed
for the bovine SILV gene represent ideal candidates for
further study into the potential effects of alternative splic-
ing on function [21].
Variation in alternative splicing of SILV with respect to 
coat color phenotype
In cattle, we did not find any mutation in the coding SILV
sequence that could convincingly be associated with
phaeomelanin coat color dilution in a F2 resource popula-
tion based on the Charolais and the Holstein breed [14].
In dogs, Clark et al., [12] described a mutation in intron
10 of the canine SILV gene that was associated with coat
color dilution and concluded that the mutation might
impair correct splicing of the canine SILV transcript. Thus,
another as yet undetected mutation in the genomic
sequence of the bovine SILV gene could possibly affect the
structure of the SILV  mRNA, representing the genetic
background for phaeomelanin dilution in cattle. Because
we could confirm SILV expression in eumelaneic and also
phaeomelaneic skin, any genetic variant affecting regula-
tion or coding structure of the gene might theoretically
also affect phaeomelanin dilution in cattle, although pres-
ently there is no indication, which function SILV may
exert on maturation of phaeomelanosomes. Thus, given
our expression data the SILV gene could not formally be
rejected as the background for phaeomelanin dilution in
cattle. However, neither the transcription start, which was
conserved between homozygous dilute (DcD/DcD) and
non-dilute (Dcd/Dcd) individuals, nor the distribution of
splice variants in the differentially pigmented skins, con-
vincingly explained the differences in dilution phenotype.
Hence, there is no indication that variation in the primary
sequence of the SILV protein either due to variation in the
coding sequence or due to alternative splicing is responsi-
ble for dilution of phaeomelanin in cattle.
Whereas the pattern of transcript variants is rather similar
across the panel of differentially pigmented skin, the vari-
ability of splice variants detected in other tissues points
towards a tissue specific splicing mechanism. This may
represent a tool for adapting SILV  expression to the
requirements of the respective cells [20].
Conclusion
Although the structure of the SILV  gene is conserved
across a variety of species including cattle, its pattern of
transcription shows substantial differences regarding
alternative splicing between cattle and human on the one
side and mice on the other. Our experiments provide evi-
dence for a ubiquitous transcription of the bovine SILV
gene not restricted to pigmented cells and show a striking
variety of alternative splice sites. These results indicate
that potentially SILV  may have functions exceeding
melanosome development. This would have to be consid-
ered in future investigations concerning melanoma diag-
nostic and therapy and also in studies taking SILV as a
model for amyloid formation [33] or for intracellular
transport mechanisms. The similarity in expression pat-
tern compared to human and the variety of alternative
transcripts predestine bovine SILV as an adequate animal
model.
Whereas alternative splicing is a well established regula-
tory mechanism for gene expression [20], the confirmed
alternative SILV transcripts are in line with the hypothesis
of the new postulated additional SILV functions exceed-
ing synthesis and deposition of melanin. This hypothesis
is supported by the detection of SILV transcripts in non-
melanophores in our study. However, it has to be consid-
ered that our analyses are restricted to the transcription
level. Thus, subsequent steps modulating SILV expression
due to e.g. nonsense mediated decay [32] and transla-
tional and posttranslational modification require further
investigation to confirm the postulated additional func-
tions of the SILV gene. Due to its extensive, up to now
unique pattern of alternative splicing, bovine splice vari-
ants represent a naturally occurring model for the func-
tion of the domains located in the spliced regions of the
SILV and for the alternative functions postulated for SILV.BMC Genomics 2007, 8:335 http://www.biomedcentral.com/1471-2164/8/335
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Furthermore, factors regulating the processes of alterna-
tive splicing in the different tissues can be investigated
exemplarily.
Methods
Tissue samples
For our study, we included individuals from a Charolais ×
German Holstein F2 cattle resource population [34]. The
resource population segregates for the coat color trait loci
(i) Dilution (Dc) responsible for coat color dilution, (ii)
Extension (E) responsible for an eumelaneic (black) or a
phaeomelaneic (red) phenotype, and (iii) Spotted  (S)
resulting in a pigmented-white spotting pattern similar to
piebald in mice. We collected differentially pigmented
neck skin after slaughter: (1) black and white sections of a
homozygous non-dilute (Dcd/Dcd), spotted (s/s) eumela-
neic (ED/Ee) animal, (2) diluted colored and white sec-
tions of an eumelaneic (ED/ED), heterozygous DcD/Dcd,
spotted (s/s) individual, (3) diluted colored and white sec-
tions of a phaeomelaneic (Ee/Ee), heterozygous DcD/Dcd,
spotted (s/s) individual and (4) the crème white skin of a
homozygous non-dilute (DcD/DcD), non-spotted, eumela-
neic (ED/ED) individual. Hair and subcutaneous tissue was
removed and the remaining cutis was snap frozen. Geno-
types of the individuals for the SILV c64G>A mutation,
presumably responsible for dilution of eumelanin, were
determined as described by [14]. Genotypes at the domi-
nant-recessive  Extension  locus were determined by
sequencing of the MC1R gene. Primers MC1RF1 (5'-TAC-
TACTTTATCTGCTGCCTG-3') and MC1RR1  (5'-GCGTA-
GAAGATGGAGATGTAG-3') flanking the causal
mutations for the alleles ED (dominant black, eumelanin)
and Ee (recessive red, phaeomelanin) were used for ampli-
fication in genomic DNA of individuals tested and consec-
utive sequencing of the resulting PCR products. In
addition to the differentially pigmented skin samples, 17
tissues (pituitary gland, thyroid gland, kidney, adrenal
gland, liver, lung, heart, brain, rumen, intestinal fat, sub-
cutaneous fat, perirenal fat, mammary gland, duodenum,
colon, jejunum, skeletal muscle) from an adult female
Charolais × German Holstein F2 individual were collected
at slaughter and immediately snap frozen. Total RNA was
isolated with the NucleoSpin® RNAII kit (Macherey and
Nagel) except all fat tissues, which were isolated with the
RNeasy Lipid tissues kit (Qiagen), essentially as described
by the manufacturers.
Analysis of skin SILV gene expression
The isolated RNA was reverse transcribed into cDNA
according to [35] with a primer mix containing Oligo
dT(12–18) and a gene specific primer from the 3'UTR of the
SILV mRNA (E11R2, Table 1). The resulting cDNAs were
amplified with GO-Taq polymerase (Promega) under
standard conditions and primers as indicated in Table 1
and Table 2. Due to confirmed splice variants in the RPT
and in the GAP3 domain of the human SILV gene and
because we obtained suggestive additional bovine SILV
transcripts in initial investigations, the entire bovine SILV
cDNA was examined for additional splice sites using over-
lapping PCR primer combinations (Table 2). These inves-
tigations were carried out in skin of different coat color
phenotypes. The generated PCR fragments were separated
on agarose gels. As a control, expression of glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) was deter-
mined by RT-PCR as described [35].
Sequencing of SILV transcripts
The analysis of SILV transcripts in differently pigmented
skin and non-pigmented body tissues detected more than
one RT-PCR fragment for several primer combinations.
The respective fragments were excised from the agarose
gel, purified using the Nucleospin Extract II kit (Macherey
and Nagel) and sequenced on a capillary sequencer (ABI
310, Applied Biosystems; MEGABACE, GE Healthcare)
using BigDye®  (Applied Biosystems) chemistry. Two
prominent RT-PCR fragments > 1000 bp generated with
primers spanning exon 1 to exon 11 (5UTRF1 – E11R2,
Table 1) were excised from the gel, purified, and cloned
into the pCR4 Blunt TOPO vector (Invitrogen) according
the manufacturers instructions. Seven size fractionated
subsets of RT-PCR fragments generated by primers enclos-
ing exon 1 to exon 7 (E1F3 – E7R1, Table 1) were excised
from the agarose gel, purified and cloned into pDrive vec-
tor (Qiagen) according to the manufacturers instructions.
Clones with different insert sizes according to colony PCR
were sequenced on a capillary sequencer (ABI 310,
Applied Biosystems; MEGABACE, GE Healthcare) using
BigDye® (Applied Biosystems) chemistry.
SILV RNA 5' RACE experiments
To determine the transcription start site for the bovine
SILV gene and to test for alternative promoters, 5' RACE
experiments with the GeneRacer Kit (Invitrogen) based on
RNA ligase mediated and oligo-capping methods were
performed. After CAP selection in a preparation of total
RNA from black skin of a eumelaneic (ED/ED), non-dilute
(Dcd/Dcd) individual, reverse transcription with oligo dT
and re-amplification with the RACE 5' oligo and a SILV
specific primer from exon 7 (RACE_E7N, Table 1) was car-
ried out according to the manufacturers instructions. The
generated fragments were cloned into pDrive vector using
the Qiagen PCR cloning kit (Qiagen). Clones with differ-
ent insert sizes according to colony PCR were sequenced.
Sequences obtained were aligned to the deposited SILV
mRNA (GenBank: EF065525).
Confirmation of SILV splice variants
To confirm the detected SILV splice variants, SILV cDNA
samples were investigated by splice site specific RT-PCR.
For this purpose, SILV cDNAs were generated by reverseBMC Genomics 2007, 8:335 http://www.biomedcentral.com/1471-2164/8/335
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transcription with the E11R2 primer from total RNA of
skins differing in coat color phenotype. Afterwards, the
cDNAs were subjected to PCR amplification with one
SILV primer corresponding to the sequence of the consti-
tutive SILV mRNA and another primer specific for each
splice variant, respectively (Table 1, Table 3). Splice vari-
ant specific primers were designed to bridge the splice
ends of the addressed alternative splice site. For negative
control, DNA of a plasmid with a constitutive SILV cDNA
insert was included.
SILV expression in non-pigmented tissues
Finally, SILV expression was screened in a collection of 17
total RNAs from non-pigmented tissues (pituitary gland,
thyroid gland, kidney, adrenal gland, liver, lung, heart,
brain, rumen, intestinal fat, subcutaneous fat, perirenal
fat, mammary gland, duodenum, colon, jejunum, skeletal
muscle). Analogous to the RT-PCR in skin tissue, the dif-
ferent RNAs were reversely transcribed and amplified by
using primers corresponding to the constitutive SILV
cDNA sequence in combinations covering exon 1 to exon
5 (E1F3/E5R1), exon 5 to exon 7 (E5F1/E7R1) and exon 9 to
exon 11 (E9F1/E11R2, Table 2).
Because there was evidence on alternative splicing in non-
pigmented skin, a collection of eight non-pigmented
other tissues (liver, duodenum, pituitary gland, lung,
heart, kidney, mammary gland) was further investigated
for alterative splicing by splice variant specific RT-PCR
analogous to the procedure described for skin. The respec-
tive primer combinations are listed in Table 3.
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